Generic Cosopt and Trusopt available now

Article

Generic versions of dorzolamide-timolol (Cosopt) and dorzolamide hydrochloride (Trusopt; Merck) are now available from Prasco.

Generic versions of Merck's dorzolamide-timolol (Cosopt) and dorzolamide hydrochloride (Trusopt; Merck) are now being marketed in the US by Prasco Laboratories, under licence from Merck.

Prasco has released a statement detailing the therapeutic equivalence of its generic versions to Merck's branded drugs. As with the branded versions, the generic formulations are contained within the Ocumeter Plus dispensing container.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Related Content
A map of Europe, and a circular frame patterned with the European Union flag, superimposed over binary code, numbers and charts. Concept image for commercialisation licensing business agreement of European pharmaceutical, EMEA ranibizumab biosimilar. Image credit: ©vectorfusionart – stock.adobe.com

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions

Martin David Harp
August 12th 2025
Article
Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
August 12th 2025
Podcast
Logos for Alcon, STAAR Surgical and the EVO ICL, on a turquoise background. Images courtesy of Alcon and STAAR Surgical.

Alcon announces acquisition of STAAR Surgical, EVO ICL lenses

Martin David Harp
August 12th 2025
Article
A teen boy or young adult man with a cane and sunglasses is walking happily next to a woman with curly hair. Concept image for NICE approval of Leber hereditary optic neuropathy therapy idebenone. Blindness vision loss and paediatric genetic eye disease. Mitochondrial inherited retinal disease. Image credit: ©Vane Nunes – stock.adobe.com

NICE announces UK approval of idebenone for treatment of Leber hereditary optic neuropathy

Hattie Hayes
August 12th 2025
Article
A woman doctor in a lab coat looks into a crystal ball. The crystal ball is on a stand. The crystal ball is purple and glowing. There are mystic magical swirls in the background. Concept image for a realistic view of diabetes remission, future of GLP-1 medications and retinopathy. Image created with Canva AI.

A realistic view of diabetes remission: GLP-1 therapies and the future of diabetic retinopathy

A. Paul Chous, MA, OD, FAAO
August 12th 2025
Article
A computer screen with a lit-up brain on it. The computer is in a laboratory. Concept image of AI artificial intelligence use in glaucoma diagnosis and treatment.

Feasibility of artificial intelligence in leading glaucoma care

Lynda Charters
August 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.